Latest Product Launches News

The a2 Milk Company posted a 12.4% rise in FY26 revenue to NZ$1.975 billion, but net profit from continuing operations fell 5.8% amid supply chain disruptions in China. The company declared a $300 million special dividend and expects mid single-digit revenue growth in FY27.

Cadence Opportunities Fund fell 2.3% in July, lagging the All Ordinaries index, but delivered a robust 26.6% gain over the past year and declared fully franked dividends yielding up to 7.4%.

Ainsworth Game Technology has locked in a critical patent licence agreement with Aristocrat, granting rights to key gaming features and responsible gaming technologies in Australia while settling past patent disputes.

Ovanti Limited is raising up to A$2.293 million through a 1-for-1 entitlement offer priced at $0.002 per share, marking a significant capital boost at a notable discount to recent trading.

SportsHero Limited has inked a deal with Razer to offer over 1,000 gaming-related digital products via its HeroPlay platform, broadening its reach beyond mobile subscriptions into consoles and PCs across Southeast Asia.

The Calmer Co. has pushed back the closing date of its $3.5 million renounceable entitlement offer to give shareholders more time to participate, including those overseas.

Resmed delivered a strong FY2026 with 10% revenue growth to $5.7 billion, a 17% rise in non-GAAP EPS, and a 10% dividend hike. Strategic moves include selling MatrixCare and acquiring Noctrix Health.

Galan Lithium is set to become a significant lithium brine producer with its Hombre Muerto West project in Argentina, targeting first sales in the second half of 2026. The company boasts a world-class resource, strong fiscal incentives, and a valuation discount to ASX peers.

AoFrio’s revenue fell 21.5% in 1H26, dragged down by a 50.5% plunge in motor sales due to US tariffs, while IoT revenue grew modestly. The company launched new cellular and software platforms, raised NZD 8.9 million, and is expanding into Food Retail, but full-year revenue growth now looks unlikely.

Atomos Limited has turned a corner in FY26, posting over 20% sales growth to around $40 million and swinging to EBITDA profitability after prior losses, boosted by new product launches and the strategic acquisition of Flanders Scientific.

Cann Group reported its second-ever quarterly operating cash inflow of $0.24 million in Q4 FY2026, edging closer to cash flow break-even. The company expanded exports to the UK and Germany, launched new products, and completed a leadership transition while redeeming convertible notes and securing additional credit.

The Calmer Co. has signed a binding heads of agreement with Kaiming Agro Processing to establish a long-term manufacturing partnership, leveraging advanced extraction technology in Fiji to scale its premium botanical ingredients business globally.